October 4, 2011
Pharmaceutical and healthcare report, “Cystic Fibrosis – Pipeline Assessment and Market Forecasts to 2017” is an essential source of information and analysis on the global cystic fibrosis market. The report identifies the key trends shaping and driving the global cystic fibrosis market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shifts in the positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global cystic fibrosis sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. http://www.bharatbook.com/detail.asp?id=128434&rt=Cystic-Fibrosis-Pipeline-Assessment-and-Market-Forecasts-to-2017.html
The report provides information on the key drivers and challenges for the global cystic fibrosis market. Its scope includes:
– Annualized global cystic fibrosis market revenues data from 2001 to 2009, forecast forward for eight years to 2017.
– Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Key classes of mechanism of action include antibiotics and anti-infective agents, ion transport modulators, anti-inflammatory agents, Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulators, nutritional supplements and Pancreatic Enzyme Replacement Therapy (PERT). ” marketing research report ”
– Analysis of the current and future market competition in the global cystic fibrosis market. Key market players covered are Cystic Fibrosis Foundation Therapeutics, Inc (CFFT), Pharmaxis, Gilead Sciences, Vertex Pharma, AstraZeneca and PARI Pharma.
– Insightful reviews of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
– Key topics covered include strategic competitor assessments, market characterization, unmet needs and the implications for the future market associated with cystic fibrosis therapeutics.
Reasons to buy
The report will enhance your decision making capability in a rapid and time sensitive manner. It will allow you to:
– Develop and design your in-licensing and out-licensing strategies through a review of the pipeline products and technologies and by identifying the companies with the most robust pipeline.
– Develop business strategies by understanding the trends shaping and driving the global cystic fibrosis market.
– Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global cystic fibrosis market in future.
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain the competitive advantage.
– Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidations, investments and strategic partnerships.
– What’s the next big thing in the global cystic fibrosis market landscape? Identify, understand and capitalize.
Cystic Fibrosis Foundation Therapeutics, Inc.
Gilead Sciences, Inc
Vertex Pharmaceuticals, Inc
For more information kindly visit :
Contact us at :
Bharat Book Bureau
Tel: +91 22 27578668 / +91 22 27579438
Fax: +91 22 27579131
Follow us on twitter: http://twitter.com/#!/Sandhya3B